Immunofluorescence 178
Hippocampal neurons were fixed in phosphate saline buffer (PBS: 10 mM sodium 179 phosphate, 130 mM NaCl, pH 7.2) containing 4% paraformaldehyde and 4% sucrose for 10 minutes 180 at room temperature, rinsed twice in PBS, permeabilized in 0.3% Triton X-100 for 15 minutes, 181 followed by two more washes in PBS. After a 1-hour incubation in 2% H 2 O 2 to block the activity of 182 the endogenous peroxidase, the immunodetection was performed using the tyramide signal 183 amplification method (Invitrogen, Paisley). In short, the fixed, permeablilized and peroxide-treated 184 neurons were incubated overnight at 4˚C with the affinity purified anti-NSK2 antibody (0.25 µg/ml, 185 see also Cingolani et al. 2002) diluted in blocking buffer. Controls were performed in parallel either 186 by omitting the purified anti-NSK2 or by using the anti-NSK2 pre-adsorbed to a SK2 fusion protein 187 (TRX-NSK2, 20 µg/ml). After repeated washes with PBS to remove the unbound primary 188 antibodies, a 1-hour incubation with the HRP-conjugated anti-rabbit secondary antibody (1:200) in 189 blocking buffer was performed. After washing the cultures with PBS, the Tyramide-Alexa Fluor 488 190 reagent was added and incubated in the dark for 5 minutes. Slides were washed, mounted using 191 pyramidal neurons in primary culture. After 10 to 18 days in vitro, neurons showed a mean resting 198 potential of -59 ± 1 mV (n = 38). 100-200 ms long somatic depolarizations to +30 mV from a 199 holding potential of -50 mV, delivered in the presence of 0.5 µM tetrodotoxin and 1 mM 200 tetraethylammonium (TEA), activated voltage-gated Ca 2+ currents, followed by an outward current. 201
The observed currents decayed with either a time constant (τ) of 222 ± 17 ms when elicited by a 202 100 ms-long depolarization (n = 8), or a τ of 485 ± 46 ms for 200 ms-long depolarizations (n = 17). 203
The mean amplitude of the outward current was 83 ± 20 pA (n = 8) in response to 100 ms-long 204 depolarizing pulses, and 140 ± 23 pA (n = 17) following 200 ms-long pulses. 205 d-Tubocurarine (dTC; 100 µM), which blocks SK channels in a reversible manner, inhibited 206 the outward current ( Fig. 1A and B) . Similarly, the specific SK channel blocker apamin (5 nM) 207 produced a strong suppression of the outward current ( Fig. 1A and B To further validate the molecular identity of the outward current and complete its 211 pharmacological characterization, we tested the SK channel enhancer 1-EBIO (250 µM) (Pedarzani 212 et al. 2001) , which increased the I AHP peak amplitude ( Fig. 1C and E) . A similar increase in I AHP 213 amplitude was observed with 5 µM of the more specific and potent SK channel enhancer 6,7-214 dichloro-1H-indole-2,3-dione3-oxime (NS309, Fig 1D and F) (Pedarzani et al. 2005 ). In addition, 215
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Taken together, these results demonstrate that the I AHP is expressed in cultured primary 218 hippocampal neurons and has similar properties to the SK-mediated I AHP recorded in pyramidal 219 neurons from acute hippocampal slices (Sailer et al. 2002; Stocker et al. 1999) . 220 221 SK2 channel expression in hippocampal neurons. 222
Evidence obtained in pharmacological and biochemical studies, and work performed on 223 genetically modified animals, point to the SK2 (K Ca 2.2) subunit as a main contributor to the 224 formation of SK channels mediating the I AHP in hippocampal neurons (Bond et al. 2004; Sailer et al. 225 2002; Stocker et al. 1999) . 226
Therefore, the distribution of SK2 channel subunits in post-natal hippocampal neurons was 227 investigated using a specific antibody (anti-NSK2) raised against the NH 2 -terminal region of the 228 SK2 protein (Cingolani et al. 2002) . Clear SK2 immunostaining was observed in the soma of the 229 neurons from 2-13 days in vitro (DIV; Fig. 2B-E) . The staining increased progressively from DIV 2. 230
Maximal expression was seen at DIV 10-13 (Fig. 2E ). For this reason neurons between DIV 10-18 231 were used for electrophysiological and imaging experiments. The SK2 immunoreactivity was visible 232 in the soma of the hippocampal pyramidal neurons and in the proximal and distal portions of 233 neurites (Fig. 2E) . Pre-adsorption of the anti-NSK2 antibodies ( neurons (Markram et al. 1995) . 287
The effect of TEA on the action potential duration (Fig. 3C ) and the amplitude and time 288 course of the fluorescence transients was reversible (Fig. 3D ). The reversibility of the effect of TEA 289 demonstrates the stability of the signals observed under our recording and imaging conditions. 290 To test whether the observed effects were a consequence of apamin acting specifically on 313 Ca 2+ influx triggered by APs rather than caused by the direct action of the depolarizing current 314 injection, we measured the impact of the SK channel inhibitor following TTX application. TTX 315 strongly attenuated the fluorescent transients (Fig. 4F, G To corroborate the result obtained with apamin, we tested the effect of a structurally 324 unrelated, small organic SK channel blocker, d-tubocurarine, on the Ca 2+ transients in the proximal 325 dendrite of hippocampal pyramidal neurons. Although less specific than apamin, dTC has the 326 advantage that it blocks SK channels in a reversible manner. Application of 100 µM dTC led to an 327 increase in the fluorescence transient amplitude to 113 ± 3% ( Fig. 5A and B) , similar to the change 328 observed with apamin. The effect of dTC on the amplitude of the fluorescence transients was 329 reversed in 5 out of 6 cells ( Fig. 5A and B) . The reversibility of the dTC effect on the amplitude of 330 the Ca 2+ transients rules out the possibility that the observed increase might be a consequence of dye 331 loading. Blocking SK channels with dTC also resulted in an increase of the area of the fluorescence 332 transients to 120 ± 4% (Fig. 5A and C) reduced both the amplitude of the fluorescence transients by 25 ± 5% ( Fig. 5D and E) and their area 341 by 30 ± 6 % ( Fig. 5D and F Hz (four APs: Fig. 6A and B ; ΔF/F = 1.72 ± 0.11; n = 18; two APS: Fig. 3-5 ; ΔF/F = 1.42 ± 0.12; 354 n = 28; P=0.02, Mann-Whitney test). The inhibition of SK channels by dTC (100 µM) resulted in an 355 increase of amplitude of the fluorescence transients to 130 ± 8% (Fig 6A-C) , and area to 144 ± 9% 356 ( Fig. 6B and E, n = 4; P<0.05). Additionally, dTC caused a prolongation of the fluorescence 357 transients by 21 ± 5% (Fig. 6D, n = saturation, we applied 10 mM TEA in the presence of dTC. As expected (see also Fig. 3C and D) , 362 TEA substantially increased the influx of Ca 2+ by prolonging the duration of the APs (Fig. 6A,  363 lower panel), thereby causing a further large increase of the fluorescence transients (Fig 6B; ( Fig. 7A and B ; n = 5). As expected, the time constant of decay of the fluorescence transients was 382 not affected by nifedipine (Fig. 7A , τ control = 414 ± 39 ms, τ Nifedipine = 423 ± 64 ms, n = 5), because τ 383 is mainly determined by Ca 2+ extrusion. The subsequent application of dTC in the presence of 384 nifedipine did not increase the amplitude of the fluorescence transients significantly ( Fig. 7A and B ; 385 When applied to neurons in the presence of nifedipine, the effect of dTC on both the amplitude and 394 the duration of the fluorescence transients was therefore strongly attenuated compared with the 395 results obtained in the absence of the L-type Ca 2+ channel blocker (Fig. 6B-D and Fig. 7A ). We 396 performed additional experiments by first applying dTC, followed by the addition of nifedipine. 397
When applied in the presence of dTC, nifedipine reduced the amplitude (F 14 decrease rapidly with distance from the soma (Callaway and Ross 1995; Christie et al. 1995; Jaffe et 412 al. 1992; Regehr et al. 1989; Regehr and Tank 1994; Spruston et al. 1995) . In this study, we have 413 investigated how the activation of SK channels affects AP-induced changes in intracellular Ca response to trains of APs (Helmchen et al. 1996; Maravall et al. 2000) . 439
Our results suggest that SK channels act in a negative feedback loop by reducing Ca al. 1995; Christie et al. 1996) . In particular, L-type Ca 2+ channels are highly 461 expressed in the somato-dendritic compartment of pyramidal cells in sections (Leitch et al. 2009; 462 Tippens et al. 2008; Westenbroek et al. 1990 ) and primary cultures (Pravettoni et al. 2000) . 463
Additionally, experiments on the specific high voltage-activated Ca (Fig. 7) or reverses it back to control values or below when nifedipine is applied 473 after dTC. This is evidence that L-type Ca (Fig. 3C-D) , SK channel inhibition does not affect the duration of somatic APs (Fig.  481 6A). However, we cannot exclude the possibility that SK channels might contribute to shaping the 482 waveform of dendritic APs, which have a lower amplitude and longer duration in CA1 dendrites 483 (Johnston et al. 2000; Spruston et al. 1995) . While the waveform of the somatic AP is not directly 484 affected by SK channel activation, the SK channel effect on AP-induced Ca because this was absent in response to pure electrotonic spread when Na + channels were blocked by 514 TTX (Fig. 4F-H) . 515
In addition to anomalous gating properties, L-type Ca The pharmacological manipulation of SK channel activity not only increased or decreased 527 the amplitude but also affected the area under the curve of the Ca 2+ transients elicited by APs in the 528 proximal dendrite of hippocampal pyramidal neurons (Fig. 4-6 ). SK channel inhibition led also to a 529 significant prolongation of the Ca 2+ transients (Fig. 4-6) . Interestingly, the L-type Ca 
